Anti-PI3 Kinase, p85, N-SH2 UB93-3 H M R IP WB Sup M IgG 200 µL 05-217
Anti-PI3 Kinase, p85a, Rb Mab H M R FC IP WB Rb IgG 100 µL 04-403
IC IH(P)
Anti-PI 3-Kinase p85α
POMC P NP_000930.1 , NP_001030333.1 y n/d n/d
77 BOB.1/OBF.1 B7810 5450 POU2AF1 M NP_006226.2 y y n/d
662 Serine/Threonine Protein Phosphatase 2C a/b P8609 5494 PPM1A P NP_066283.1 y y n/d
608 Protein Phosphatase
POMC P NP_000930.1 , NP_001030333.1 y n/d n/d
77 BOB.1/OBF.1 B7810 5450 POU2AF1 M NP_006226.2 y y n/d
662 Serine/Threonine Protein Phosphatase 2C a/b P8609 5494 PPM1A P NP_066283.1 y y n/d
608 Protein Phosphatase
POMC P NP_000930.1 , NP_001030333.1 y n/d n/d
77 BOB.1/OBF.1 B7810 5450 POU2AF1 M NP_006226.2 y y n/d
662 Serine/Threonine Protein Phosphatase 2C a/b P8609 5494 PPM1A P NP_066283.1 y y n/d
608 Protein Phosphatase
(20):5437-47.
3. Holm C et al. Phosphorylation of the oestrogen receptor alpha at serine
305 and prediction of tamoxifen resistance in breast cancer. J Pathol.
2009 Feb;217(3):372-9.
4. Kok
17-10457
Magna ChIP® Protein A Magnetic Beads 16-661
Magna ChIP® Protein G Magnetic Beads 16-662
Magna ChIP® Protein A+G Magnetic Beads 16-663
RNA
Immunoprecipitation
(RIP)
EZ-Magna ChIRP
Phosphatase 2 A/Bγ P5359 P y y y
661 Serine/Threonine Protein Phosphatase 2 A/B′ pan2 P8359 P n/d n/d y
662 Serine/Threonine Protein Phosphatase 2C α/β P8609 P y y n/d
663 AP2 gamma NA M y n/d n/d
664 SGK S5188
flexible nature of these polymers.
References:
(1) Loo, Y.-L.; McCulloch, I. MRS Bull. 2008, 33, 653-662.
(2) Cantatore, E.; Geuns, T. C. T.; Gelinck, G. H.; van Veenendaal, E.; Gruijthuijsen,
A. F.
N-SH3 AB6 H M IP WB IC Pur M IgG1κ 100 µg 05-212
Anti-PI3 Kinase, p85, N-SH2 UB93-3 H M R IP WB Sup M IgG 200 µL 05-217
Anti-PI3 Kinase, p110δ AW103 H WB Pur M IgG1κ